Moffitt Cancer Center
Tampa, Florida, 33612, United States
NCT Number: NCT04464668
This study is to assess the impact of the CARES-REACH intervention on colorectal cancer screening rates.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Tampa, Florida, 33612, United States
This study will not accrue individual patients. Instead, the investigators are collecting process data from health care providers to determine the procedures that impact or help to increase colorectal cancer screening rates.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Providers will be trained to use Electronic Medical Record (EMR) tools and prompts, and an organization wide cancer control champion will be trained to motivate providers and navigate patients.
Remote/electronic data collection surveys will be conducted with clinic institution leaders, cancer control champions, and providers from various clinic locations to solicit feedback about implementation processes at three time points (baseline, mid-point and end of study implementation)
Time frame: Years 1-5
Percentage of patients who complete initial Fecal Immunochemical Test (FIT)
Time frame: Years 1-5
Percentage of patients who complete a repeat Fecal Immunochemical Test (FIT)
Time frame: Years 2-5
Screening rate differences to determine how variables such as clinic setting (rural vs urban), population characteristics such as nativity (foreign born status), language preference, education, income, health insurance, etc. differentially impact annual clinic Colorectal Cancer (CRC) screening rates.
H. Lee Moffitt Cancer Center and Research Institute
Other
Acronym: CARES-REACH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06305247
Carcinoma, Carcinoma, Squamous Cell
Los Angeles, California, United States
View Trial DetailsNCT05464030
Colonic Diseases, Colorectal Cancer
Encinitas, California, United States
View Trial DetailsNCT04117087
Colonic Diseases, Colonic Neoplasms
Baltimore, Maryland, United States
View Trial DetailsNCT04258137
Bronchial Neoplasms, Carcinoma, Bronchogenic
Bayonne, France
View Trial Details